Testosterone is going mainstream. What used to be the stuff of bodybuilders is growing in popularity for everything from treating medical conditions to giving looksmaxxers an edge.
Now, big-name players like Hims and Rugiet are entering the testosterone space, which is rife with gray market providers — including some seemingly faceless, shady companies.
Inc.’s Sam Blum joins Chloe Aiello to take us into the red-pilled world of testosterone replacement therapy.
Then, Sam and Chloe talk over their news obsessions this week including GLP-1s and eating disorders, and a battle between prediction markets Kalshi and Polymarket.
Also, an update on our brand: This Monday edition of The Business Model, which we had been calling “Circling Back,” will now be called “1 Smart Business Story.” Why? Well, Inc. just launched a new newsletter on Beehiiv with the same name. Subscribe today to get a can’t-miss business story every week in both newsletter and podcast form.
If you happened to have an affinity for the “Circling Back” brand, don’t worry: Our closing segment at the end of each Monday episode will now be called “Circling Back,” where we fill you in on what we are obsessed with right now.